{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T21:51:35Z","timestamp":1776894695858,"version":"3.51.2"},"reference-count":25,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T00:00:00Z","timestamp":1684454400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100014569","name":"Sociedad Espa\u00f1ola de Farmacia Hospitalaria","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014569","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Farmacia Hospitalaria"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.farma.2023.05.005","type":"journal-article","created":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:59:41Z","timestamp":1688173181000},"page":"T155-T160","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["[Translated Article] Disease-modifying treatments for patients with multiple sclerosis in Spain"],"prefix":"10.1016","volume":"47","author":[{"given":"Alejandro Santiago","family":"P\u00e9rez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Santos Esteban","family":"Casado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miriam \u00c1lvarez","family":"Payero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c1ngel Escolano","family":"Pueyo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c1ngel Guillermo Ar\u00e9valo","family":"Bernab\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N\u00faria Padull\u00e9s","family":"Zamora","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pilar Diaz","family":"Ruiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Mar\u00eda L\u00f3pez","family":"Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl 2","key":"10.1016\/j.farma.2023.05.005_bb0005","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1017\/S0317167100022393","article-title":"Multiple sclerosis: autoimmune disease or autoimmune reaction?","volume":"37","author":"Stys","year":"2010","journal-title":"Can J Neurol Sci"},{"key":"10.1016\/j.farma.2023.05.005_bb0010","author":"Atlas de esclerosis m\u00faltiple [Internet]"},{"key":"10.1016\/j.farma.2023.05.005_bb0015","first-page":"1","article-title":"Incidencia y prevalencia de la esclerosis m\u00faltiple en Espa\u00f1a. Una revisi\u00f3n sistem\u00e1tica","volume":"1734","author":"Garc\u00eda L\u00f3pez","year":"2022","journal-title":"Neurolog\u00eda."},{"key":"10.1016\/j.farma.2023.05.005_bb0020","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1212\/WNL.0000000000000560","article-title":"Defining the clinical course of multiple sclerosis: The 2013 revisions","volume":"83","author":"Lublin","year":"2014","journal-title":"Neurology."},{"key":"10.1016\/j.farma.2023.05.005_bb0025","series-title":"Gu\u00eda diagn\u00f3stica y terap\u00e9uticas de la Sociedad Espa\u00f1ola de Neurolog\u00eda","author":"Rodr\u00edguez Antig\u00fcedad","year":"2014"},{"issue":"2","key":"10.1016\/j.farma.2023.05.005_bb0030","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/ene.13536","article-title":"ECTRIMS\/EAN guideline on the pharmacological treatment of people with multiple sclerosis","volume":"25","author":"Montalban","year":"2018","journal-title":"Eur J Neurol"},{"issue":"2","key":"10.1016\/j.farma.2023.05.005_bb0035","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.nrleng.2016.02.003","article-title":"Consensus statement on the treatment of multiple sclerosis by the Spanish Society of Neurology in 2016","volume":"32","author":"Garc\u00eda Merino","year":"2017","journal-title":"Neurolog\u00eda (English Edition)"},{"issue":"08","key":"10.1016\/j.farma.2023.05.005_bb0040","doi-asserted-by":"crossref","first-page":"359","DOI":"10.33588\/rn.5708.2013374","article-title":"Documento de consenso sobre la espasticidad en pacientes con esclerosis m\u00faltiple","volume":"57","author":"Oreja-Guevara","year":"2013","journal-title":"Rev Neurol"},{"issue":"9","key":"10.1016\/j.farma.2023.05.005_bb0045","doi-asserted-by":"crossref","first-page":"3147","DOI":"10.1093\/brain\/awac016","article-title":"How patients with multiple sclerosis acquire disability","volume":"145","author":"Lublin","year":"2022","journal-title":"Brain."},{"key":"10.1016\/j.farma.2023.05.005_bb0050","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1177\/1352458514564491","article-title":"A systematic review of the incidence and prevalence of comorbidity in multiple sclerosis: overview","volume":"21","author":"Marrie","year":"2015","journal-title":"Mult Scler J"},{"key":"10.1016\/j.farma.2023.05.005_bb0055","doi-asserted-by":"crossref","first-page":"851","DOI":"10.3389\/fneur.2020.00851","article-title":"Comorbidity in multiple sclerosis","volume":"11","author":"Magyari","year":"2020","journal-title":"Front Neurol"},{"issue":"3","key":"10.1016\/j.farma.2023.05.005_bb0060","first-page":"239","article-title":"Polypharmacy in multiple sclerosis: current knowledge and future directions","volume":"118","author":"Thelen","year":"2021","journal-title":"Mo Med"},{"key":"10.1016\/j.farma.2023.05.005_bb0065","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1111\/ene.12518","article-title":"Multiple sclerosis clinical course and cardiovascular disease risk\u2014Swedish cohort study","volume":"21","author":"Roshanisefat","year":"2014","journal-title":"Eur J Neurol"},{"issue":"1","key":"10.1016\/j.farma.2023.05.005_bb0070","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1186\/s12877-017-0621-2","article-title":"What is polypharmacy? A systematic review of definitions","volume":"17","author":"Masnoon","year":"2017","journal-title":"BMC Geriatr"},{"issue":"2","key":"10.1016\/j.farma.2023.05.005_bb0075","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1080\/14740338.2020.1720646","article-title":"Polypharmacy among patients with multiple sclerosis: a qualitative systematic review","volume":"19","author":"Frahm","year":"2020","journal-title":"Expert Opin Drug Saf"},{"issue":"1","key":"10.1016\/j.farma.2023.05.005_bb0080","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0211120","article-title":"Polypharmacy in outpatients with relapsing remitting multiple sclerosis: a single-center study","volume":"14","author":"Frahm","year":"2019","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.farma.2023.05.005_bb0085","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0084967","article-title":"Polypharmacy patterns: unraveling systematic associations between prescribed medications","volume":"8","author":"Calder\u00f3n-Larra\u00f1aga","year":"2013","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.farma.2023.05.005_bb0090","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1345\/aph.1D479","article-title":"Development and validation of the medication regimen complexity index","volume":"38","author":"George","year":"2004","journal-title":"Ann Pharmacother"},{"issue":"2S","key":"10.1016\/j.farma.2023.05.005_bb0095","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1177\/1352458517708672","article-title":"New insights into the burden and costs of multiple sclerosis in Europe: results for Spain","volume":"23","author":"Oreja-Guevara","year":"2017","journal-title":"Mult Scler J"},{"issue":"1","key":"10.1016\/j.farma.2023.05.005_bb0100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0211120","article-title":"Polypharmacy in outpatients with relapsing\u2013remitting multiple sclerosis: a single-center study","volume":"14","author":"Frahm","year":"2019","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.farma.2023.05.005_bb0105","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s13293-019-0243-9","article-title":"Polypharmacy in patients with multiple sclerosis: a gender-specific analysis","volume":"10","author":"Frahm","year":"2019","journal-title":"Biol Sex Differ"},{"issue":"5","key":"10.1016\/j.farma.2023.05.005_bb0110","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.jpsychores.2014.02.013","article-title":"Polypharmacy in multiple sclerosis: relationship with fatigue, perceived cognition, and objective cognitive performance","volume":"76","author":"Thelen","year":"2014","journal-title":"J Psychosom Res"},{"key":"10.1016\/j.farma.2023.05.005_bb0115","article-title":"Antiepileptic and antidepressive polypharmacy in patients with multiple sclerosis","volume":"2015","author":"Beiske","year":"2015","journal-title":"Mult Scler Int"},{"key":"10.1016\/j.farma.2023.05.005_bb0120","doi-asserted-by":"crossref","DOI":"10.1177\/2040622320983121","article-title":"Exploring polypharmacy phenomenon in newly diagnosed relapsing\u2013remitting multiple sclerosis: a cohort ambispective single-centre study","volume":"12","author":"Zangh\u00ec","year":"2021","journal-title":"Ther Adv Chronic Dis"},{"issue":"11","key":"10.1016\/j.farma.2023.05.005_bb0125","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1177\/1060028016656385","article-title":"Cross-cultural adaptation and validation of the medication regimen complexity index adapted to Spanish","volume":"50","author":"Saez de la Fuente","year":"2016","journal-title":"Ann Pharmacother"}],"container-title":["Farmacia Hospitalaria"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S113063432300051X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S113063432300051X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T04:17:24Z","timestamp":1761106644000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S113063432300051X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["S113063432300051X"],"URL":"https:\/\/doi.org\/10.1016\/j.farma.2023.05.005","relation":{},"ISSN":["1130-6343"],"issn-type":[{"value":"1130-6343","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"[Translated Article] Disease-modifying treatments for patients with multiple sclerosis in Spain","name":"articletitle","label":"Article Title"},{"value":"Farmacia Hospitalaria","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.farma.2023.05.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.farma.2023.03.009","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Sociedad Espa\u00f1ola de Farmacia Hospitalaria (S.E.F.H). Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}